On October 6, 2022 Kenneth L. Waggoner, president and general counsel of PharmaCyte Biotech, Inc. (the Company) resigned from his position as an employee of the company and its direct and indirect subsidiaries and affiliates (collectively, the Company Group) and as a director on the board of directors of the company (the board). Effective October 6, 2022, the board appointed Joshua N. Silverman, a director on the board since August 2022, as interim chairman of the board and interim president of the company. Mr. Silverman is expected to serve in such capacities for an indeterminate amount of time and is expected to enter into a compensatory agreement, which will occur in the near future.

Joshua N. Silverman is currently a director of the company and the Co-Founder and Managing Member of Parkfield Funding LLC and is a former Principal and Managing Partner of Iroquois Capital Management, LLC. Mr. Silverman served as Co-Chief Investment Officer of Iroquois from 2003 until July 2016. From 2000 to 2003, Mr. Silverman served as Co-Chief Investment Officer of Vertical Ventures, LLC, a merchant bank.

Prior to forming Iroquois, Mr. Silverman was a Director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, Mr. Silverman served as Assistant Press Secretary to The President of The United States. Mr. Silverman received his B.A. from Lehigh University.